AstraZeneca and Daiichi’s breast cancer drug gets EU backing
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in the U.S. and Japan.
Tomas Kauer - News Moderator 
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in the U.S. and Japan.
